For the Inventor, By the Inventor

Enter assignee name

Wilmington, DE, United States of America

Lilly Icos LLC

USPTO Granted Patents = 25

% Expired Patents = 76.0

CIPO Patents = 1

Trademarks = 2

Forward Citations = 187

Loading Chart...

Loading Chart...

31 inventors (with patents filed for the assignee):

Mark W Orme (18 out of 68 patents)

Jason Scott Sawyer (17 out of 72 patents)

Lisa M Schultze (10 out of 10 patents)

4. Alain Claude-Marie Daugan (7 out of 26 patents)

5. Neil R Anderson (3 out of 7 patents)

6. Raymond F Brown (3 out of 3 patents)

7. Agnes Bombrun (3 out of 3 patents)

8. William Ernest Pullman (3 out of 3 patents)

9. Kenneth M Ferguson (2 out of 5 patents)

10. Romain Luc Marie Gosmini (2 out of 10 patents)

11. Martha A Kral (2 out of 2 patents)

12. Françoise Jeanne Gellibert (2 out of 3 patents)

13. John Steven Whitaker (2 out of 2 patents)

14. Romain Luc Gosmini (2 out of 3 patents)

15. Nerina Dodic (1 out of 6 patents)

25 patents: Sort by Forward Citations

1. 7550479 - Modified Pictet-Spengler reaction and products prepared therefrom (2009-06-23),

2. 7338955 - Medicament for treatment of neuropathies (2008-03-04),

3. 7182958 - β-carboline pharmaceutical compositions (2007-02-27),

4. 7122554 - Carboline derivatives (2006-10-17),

5. 7115621 - Chemical compounds (2006-10-03),

6. 7105506 - Tetracyclic compounds as PDE5-inhibitors (2006-09-12),

7. 7098209 - Pyrazino [1'2':1,6 ] pyrido [3, 4-b] indole-1,4-dione derivatives (2006-08-29),

8. 7034027 - Fused heterocyclic derivatives as phosphodiesterase inhibitors (2006-04-25),

9. 7022856 - Carboline derivatives (2006-04-04),

10. 6992192 - Carboline derivatives as PDE5 inhibitors (2006-01-31),

11. 6984641 - Carboline derivatives as PDE5 inhibitors (2006-01-10),

12. 6962918 - Hexahydropyrazino[1'2';1,6]pyrido[3,4-b]indole-1,4-diones for the treatment of cardiovascular disorders and erectile dysfunction (2005-11-08),

13. 6960587 - Condensed pyrazindione derivatives as PDE inhibitors (2005-11-01),

14. 6943166 - Compositions comprising phosphodiesterase inhabitors for the treatment of sexual disfunction (2005-09-13),

15. 6911542 - Pyrazino[1',2′:1,6]pyrido[3,4b]indole derivatives (2005-06-28),

Lilly ICOS LLC is a biopharmaceutical company focused on the development and commercialization of innovative therapies. The company specializes in the research, production, and marketing of pharmaceutical products. With a dedication to improving patient's lives, Lilly ICOS strives to discover breakthrough solutions for the treatment of various medical conditions.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

25 Patents

#187 in Wilmington, DE

#226 in Delaware

#13,334 in US

#25,651 in the World

Wilmington, DE, United States of America

Lilly Icos LLC

Forward Citations = 187

31 inventors:

Mark W Orme (18 out of 68 patents)

Jason Scott Sawyer (17 out of 72 patents)

Lisa M Schultze (10 out of 10 patents)

4. Alain Claude-Marie Daugan (7 out of 26 patents)

5. Neil R Anderson (3 out of 7 patents)

Please report any incorrect information to [email protected]

Loading…